1ST DECEMBER 2022

HKBMIA Exchange Meeting

HKBMIA hosted the Exchange meeting on 1st December 2022 – the New Chapter of Hong Kong's life science industry. After President Prof. Yuk Lam Lo welcoming all the members and peers engaged in the life science industry, including representatives from Invest.HK, HKSTP, Guangdong-Hong Kong-Macau Greater Bay Area and European. During the meeting, the Chief Operating Officer reported HKBMIA's recent activities and upcoming plans to the guests. There were also four members presenting during the meeting:

1.Dr Xiaoyi Li, the Founder and Executive Director of Lee’s Pharma

2.Dr Ming Li, the CEO of ZSHK laboratories

3.Mr Samson Lau, the CEO of PrimaNova

4.Mr Maarten Brusse, the General Manager APAC & Global Lab Integration of Cerba Research

It is remarkable that Cebra Research, a member that has recently joined us, is dedicated to providing designing and management services for clinical trials for pharmaceutical and biotechnology products. The company is capable of providing central lab services in routine and specialized testings for a wide variety of medical specialities, such as oncology, immunology, genetics, microbiology and clinical pathology. Its laboratories routinely conduct medical clinical testings to ensure that there are tests performed on a daily basis for diagnostic purposes, patient stratification, staging and follow-up. With cutting-edge technologies at its disposal, Cerba research's medical and scientific experts are specialists in their fields equipped for delivering more than just testing.